For: | Rudholm T, Hellström PM, Theodorsson E, Campbell CA, McLean PG, Näslund E. Bravo capsule system optimizes intragastric pH monitoring over prolonged time: Effects of ghrelin on gastric acid and hormone secretion in the rat. World J Gastroenterol 2008; 14(40): 6180-6187 [PMID: 18985808 DOI: 10.3748/wjg.14.6180] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6180.htm |
Number | Citing Articles |
1 |
|
2 |
Yohei Kosugi, Syunsuke Yamamoto, Noriyasu Sano, Atsutoshi Furuta, Tomoko Igari, Yasushi Fujioka, Nobuyuki Amano. Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion. Journal of Pharmaceutical Sciences 2015; 104(9): 2887 doi: 10.1002/jps.24401
|
3 |
Kelly M. Mahar, Samm Portelli, Robert Coatney, Emile P. Chen. Gastric pH and Gastric Residence Time in Fasted and Fed Conscious Beagle Dogs using the Bravo® pH System. Journal of Pharmaceutical Sciences 2012; 101(7): 2439 doi: 10.1002/jps.23159
|
4 |
J. Bazelle, A. Threlfall, N. Whitley. Gastroprotectants in small animal veterinary practice – a review of the evidence. Part 1: cyto‐protective drugs. Journal of Small Animal Practice 2018; 59(10): 587 doi: 10.1111/jsap.12867
|
5 |
Dominic-Luc Webb, Tobias Rudholm-Feldreich, Linda Gillberg, Md. Abdul Halim, Elvar Theodorsson, Gareth J. Sanger, Colin A. Campbell, Malcolm Boyce, Erik Näslund, Per M. Hellström. The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression. Naunyn-Schmiedeberg's Archives of Pharmacology 2013; 386(1): 41 doi: 10.1007/s00210-012-0812-5
|